Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Aditya K. Gupta, Maanasa Venkataraman, Neil H. Shear & Vincent Piguet. (2022) Onychomycosis in children – review on treatment and management strategies. Journal of Dermatological Treatment 33:3, pages 1213-1224.
Read now
Read now
Aditya K. Gupta, Steve Hall, Lee T. Zane, Shari R. Lipner & Phoebe Rich. (2018) Evaluation of the efficacy and safety of tavaborole topical solution, 5%, in the treatment of onychomycosis of the toenail in adults: a pooled analysis of an 8-week, post-study follow-up from two randomized phase 3 studies. Journal of Dermatological Treatment 29:1, pages 44-48.
Read now
Read now
Sphoorthi Jinna & Justin Finch. (2015) Spotlight on tavaborole for the treatment of onychomycosis. Drug Design, Development and Therapy 9, pages 6185-6190.
Read now
Read now
Articles from other publishers (34)
Pravin D. HarakAmar G. ZalteVishal S. Gulecha. (2023) Formulation and Evaluation of Film Forming Solution of Tavaborole for Treatment of Skin Infections. Research Journal of Pharmacy and Technology, pages 1342-1346.
Crossref
Crossref
Wen-Bin Zhao, Jun-Xia An, Yong-Mei Hu, An-Ping Li, Shao-Yong Zhang, Bao-Qi Zhang, Zhi-Jun Zhang, Xiong-Fei Luo, Qiang Bian, Yue Ma, Yan-Yan Ding, Rui Wang & Ying-Qian Liu. (2022)
Tavaborole-Induced Inhibition of the Aminoacyl-tRNA Biosynthesis Pathway against
Botrytis cinerea
Contributes to Disease Control and Fruit Quality Preservation
. Journal of Agricultural and Food Chemistry 70:39, pages 12297-12309.
Crossref
Crossref
Vikas Agrawal, Rashmin Patel & Mrunali Patel. (2022) Tavaborole microemulsion: New strategy for the targeted treatment of onychomycosis. Journal of Drug Delivery Science and Technology 74, pages 103494.
Crossref
Crossref
Bhaskar C. Das, Mohammed Adil Shareef, Sasmita Das, Nitesh K. Nandwana, Yogarupa Das, Mariko Saito & Louis M. Weiss. (2022) Boron-Containing heterocycles as promising pharmacological agents. Bioorganic & Medicinal Chemistry 63, pages 116748.
Crossref
Crossref
Vasco Silva-Neves, Ana Caramelo, Paulo Alves, Carla Pais-Vieira, Alexandra Palmer Minton, Ana María Rodríguez-Leboeuf & Miguel Pais-Vieira. (2021) Translation and Cross-Cultural Adaptation of Quality of Life Scale in Patients with Onychomycosis. International Journal of Environmental Research and Public Health 18:11, pages 5793.
Crossref
Crossref
Keita Sugiura, Akane Masumoto, Haruki Tachibana & Yoshiyuki Tatsumi. (2021) In Vitro Combination Effect of Topical and Oral Anti-Onychomycosis Drugs on Trichophyton rubrum and Trichophyton interdigitale. Journal of Fungi 7:3, pages 208.
Crossref
Crossref
Aditya K. Gupta, Rachel R. Mays & Kelly A. Foley. 2021. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy
480
492.e5
.
Dorota Wieczorek, Ewa Kaczorowska, Marta Wiśniewska, Izabela D. Madura, Magdalena Leśniak, Jacek Lipok & Agnieszka Adamczyk-Woźniak. (2020) Synthesis and Influence of 3-Amino Benzoxaboroles Structure on Their Activity against Candida albicans. Molecules 25:24, pages 5999.
Crossref
Crossref
A.K. Gupta, N. Stec, R.C. Summerbell, N.H. Shear, V. Piguet, A. Tosti & B.M. Piraccini. (2020) Onychomycosis: a review. Journal of the European Academy of Dermatology and Venereology 34:9, pages 1972-1990.
Crossref
Crossref
R. Aggarwal, M. Targhotra, B. Kumar, P.K. Sahoo & M.K. Chauhan. (2020) Treatment and management strategies of onychomycosis. Journal de Mycologie Médicale 30:2, pages 100949.
Crossref
Crossref
Ken IOZUMI & Shinichi WATANABE. (2020) Efficacy of Long-Term Treatment with Efinaconazole 10% Solution in Patients with Onychomycosis, Including Severe Cases : A Multicenter, Single-Arm Study重症例を含む爪白癬患者に対するエフィナコナゾール爪外用液 10% の長期使用時における有効性の検討. Nishi Nihon Hifuka 82:2, pages 103-111.
Crossref
Crossref
Esra DİBEK, Anara BABAYEVA, Merve SEZER KÜRKÇÜ, Nihan AKGÜÇ ÇÖL & Bekir ÇÖL. (2020) Bor içeren bazı antibiyotikler. Journal of Boron, pages 29-39.
Crossref
Crossref
Katrien Van Bocxlaer, Diana Caridha, Chad Black, Brian Vesely, Susan Leed, Richard J. Sciotti, Gert-Jan Wijnant, Vanessa Yardley, Stéphanie Braillard, Charles E. Mowbray, Jean-Robert Ioset & Simon L. Croft. (2019) Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis. International Journal for Parasitology: Drugs and Drug Resistance 11, pages 129-138.
Crossref
Crossref
Zhu Yinghuai, Xinglong Lin, Hongming Xie, Jianlin Li, Narayan S. Hosmane & Yingjun Zhang. (2019) The Current Status and Perspectives of Delivery Strategy for Boronbased Drugs. Current Medicinal Chemistry 26:26, pages 5019-5035.
Crossref
Crossref
Roderick J. Hay, Boni Elewski, Bianca Maria Piraccini, Nikki Sullivan, Casey Wang & Robert Baran. 2019. Baran & Dawber's Diseases of the Nails and their Management. Baran & Dawber's Diseases of the Nails and their Management
349
389
.
Daniela Begolo, Isabel M. Vincent, Federica Giordani, Ina Pöhner, Michael J. Witty, Timothy G. Rowan, Zakaria Bengaly, Kirsten Gillingwater, Yvonne Freund, Rebecca C. Wade, Michael P. Barrett & Christine Clayton. (2018) The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing. PLOS Pathogens 14:9, pages e1007315.
Crossref
Crossref
Aditya K. Gupta, Rachel R. Mays, Sarah G. Versteeg, Neil H. Shear & Sheila F. Friedlander. (2018) Onychomycosis in children: Safety and efficacy of antifungal agents. Pediatric Dermatology 35:5, pages 552-559.
Crossref
Crossref
Casey Wang, Theresa Canavan & Boni Elewski. 2018. Onychomycosis. Onychomycosis
103
117
.
Elena Cutrín Gómez, Soledad Anguiano Igea, José Luis Gómez Amoza & Francisco J. Otero Espinar. (2018) Evaluation of the promoting effect of soluble cyclodextrins in drug nail penetration. European Journal of Pharmaceutical Sciences 117, pages 270-278.
Crossref
Crossref
Haruki Tachibana, Naomichi Kumagai & Yoshiyuki Tatsumi. (2017) Fungicidal Activity in the Presence of Keratin as an Important Factor Contributing to In Vivo Efficacy: A Comparison of Efinaconazole, Tavaborole, and Ciclopirox. Journal of Fungi 3:4, pages 58.
Crossref
Crossref
. 2017. Carrier‒Mediated Dermal Delivery. Carrier‒Mediated Dermal Delivery
503
554
.
Tracey C. Vlahovic. 2017. Onychomycosis. Onychomycosis
197
203
.
Tracey C. VlahovicWarren S. JosephRichard K. ScherAntonella TostiJesse PlasenciaDavid M. PariserBryan C. Markinson. (2016) Diagnosis and Management of Onychomycosis. Journal of the American Podiatric Medical Association 106:2, pages 155-162.
Crossref
Crossref
Hanchao Zhao, Andres Palencia, Elena Seiradake, Zhaleh Ghaemi, Stephen Cusack, Zaida Luthey-Schulten & Susan Martinis. (2015) Analysis of the Resistance Mechanism of a Benzoxaborole Inhibitor Reveals Insight into the Leucyl-tRNA Synthetase Editing Mechanism. ACS Chemical Biology 10:10, pages 2277-2285.
Crossref
Crossref
Sarah J. Burke, James M. Gamrat, Jacqueline R. Santhouse, Dylan T. Tomares & John W. Tomsho. (2015) Potassium haloalkyltrifluoroborate salts: synthesis, application, and reversible ligand replacement with MIDA. Tetrahedron Letters 56:41, pages 5500-5503.
Crossref
Crossref
M. Rosa Sánchez Casado, Myriam Ciordia Jiménez, Manuela Ariza Bueno, Morgane Barriol, Joseph E. Leenaerts, Chiara Pagliuca, Carolina Martínez Lamenca, Ana Isabel De Lucas, Aránzazu García, Andrés A. Trabanco & Frederik J. R. Rombouts. (2015) Synthesis of 2,1-Borazaroquinolines and 2,1-Borazaroisoquinolines from Vinylaminopyridines and Potassium Organotrifluoroborates by Microwave-Assisted Heating. European Journal of Organic Chemistry 2015:23, pages 5221-5229.
Crossref
Crossref
Boni E. Elewski, Raza Aly, Sheryl L. Baldwin, Remigio F. González Soto, Phoebe Rich, Max Weisfeld, Hector Wiltz, Lee T. Zane & Richard Pollak. (2015) Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies. Journal of the American Academy of Dermatology 73:1, pages 62-69.
Crossref
Crossref
Matilde Iorizzo. (2015) Tips to Treat the 5 Most Common Nail Disorders. Dermatologic Clinics 33:2, pages 175-183.
Crossref
Crossref
Bianca Piraccini & Aurora Alessandrini. (2015) Onychomycosis: A Review. Journal of Fungi 1:1, pages 30-43.
Crossref
Crossref
Yoshiyuki Tatsumi. (2015) Pharmacological characteristics and clinical results of efinaconazole (Clenafin<sup>®</sup> Topical Solution 10%), a novel anti-onychomycosis drug. Folia Pharmacologica Japonica 145:5, pages 250-258.
Crossref
Crossref
John M. Evans, Apphia L. Wang & Boni E. Elewski. (2015) Successful Treatment of Paecilomyces lilacinus Onychomycosis with Efinaconazole and Tavaborole. Skin Appendage Disorders 1:4, pages 169-171.
Crossref
Crossref
John Montgomery Yost. 2015. Advances in Geriatric Dermatology. Advances in Geriatric Dermatology
41
54
.
Anthony Markham. (2014) Tavaborole: First Global Approval. Drugs 74:13, pages 1555-1558.
Crossref
Crossref
F.J. Dowd. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.